Recently, the National Pharmaceutical Engineering Control Company successfully won the bid of Jiangsu Nuotai Ausano Biopharmaceutical Co., Ltd. polypeptide API workshop construction project.

The project is located in Lianyungang Economic and Technological Development Zone, covers an area of 7000 square meters, with a total investment of about 2.1Billion yuan, the construction content includes innovative drug development (protein peptide drugs, chemical drugs), research and development outsourcing services (customer peptide custom synthesis) and drug active ingredients (pharmaceutical APIs) industrial production.

Sinopharm engineering automatic control company will use this bid as an opportunity to continue to increase in the biomedical automation control field of research and development investment, and actively explore cutting-edge technology, and constantly improve their technical level and innovation capabilities.

(Automatic Control Company)